Literature DB >> 27875736

Emerging roles and mechanisms of long noncoding RNAs in atherosclerosis.

Yao Liu1, Lei Zheng1, Qian Wang1, Yan-Wei Hu2.   

Abstract

Atherosclerosis is the most common cause of heart attacks, strokes, and peripheral vascular disease. Atherosclerosis is predicted to be the primary cause of death in the world by 2020. Increasing evidence suggests that long non-protein-coding RNAs (lncRNAs) are important for the regulation of tissue homeostasis and pathophysiological conditions. Although knowledge about lncRNAs in atherosclerosis and other cardiovascular diseases is sparse, lncRNAs are clinically interesting because of their diagnostic and therapeutic value. This review summarizes knowledge about lncRNAs through their actions, related research methods and effects on atherosclerosis to provide helpful insights about how lncRNAs work and control atherosclerosis process and how lncRNA-related strategies could benefit human beings.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cell proliferation; Inflammatory response; Lipid metabolism; lncRNA

Mesh:

Substances:

Year:  2016        PMID: 27875736     DOI: 10.1016/j.ijcard.2016.11.182

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  36 in total

1.  Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing.

Authors:  Valentina Lo Sardo; Pavel Chubukov; William Ferguson; Aditya Kumar; Evan L Teng; Michael Duran; Lei Zhang; Gregory Cost; Adam J Engler; Fyodor Urnov; Eric J Topol; Ali Torkamani; Kristin K Baldwin
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

Review 2.  Atherosclerosis Is an Epigenetic Disease.

Authors:  Suowen Xu; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Trends Endocrinol Metab       Date:  2018-05-10       Impact factor: 12.015

3.  GAS5 knockdown suppresses inflammation and oxidative stress induced by oxidized low-density lipoprotein in macrophages by sponging miR-135a.

Authors:  Yunyan Zhang; Xianben Lu; Minjun Yang; Jiaolin Shangguan; Yanping Yin
Journal:  Mol Cell Biochem       Date:  2020-10-31       Impact factor: 3.396

Review 4.  Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases.

Authors:  Chongtae Kim; Donghee Kang; Eun Kyung Lee; Jae-Seon Lee
Journal:  Oxid Med Cell Longev       Date:  2017-07-25       Impact factor: 6.543

Review 5.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

Review 6.  Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis.

Authors:  Wen-Chu Ye; Shi-Feng Huang; Lian-Jie Hou; Hai-Jiao Long; Kai Yin; Ching Yuan Hu; Guo-Jun Zhao
Journal:  Front Cardiovasc Med       Date:  2021-06-10

7.  LncRNA SNHG12 regulates ox-LDL-induced endothelial cell injury by the miR-218-5p/IGF2 axis in atherosclerosis.

Authors:  Ping Mao; Xiaowei Liu; Yingzheng Wen; Lijiang Tang; Yimin Tang
Journal:  Cell Cycle       Date:  2021-07-27       Impact factor: 5.173

8.  Long non-coding RNA ZFAS1 correlates with clinical progression and prognosis in cancer patients.

Authors:  Fangteng Liu; Hui Gao; Siyu Li; Xiaolin Ni; Zhengming Zhu
Journal:  Oncotarget       Date:  2017-06-27

9.  H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.

Authors:  Lei Zhang; Hailing Cheng; Yuxia Yue; Shuangzhan Li; Daping Zhang; Ruili He
Journal:  J Biomed Sci       Date:  2018-02-07       Impact factor: 8.410

10.  MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice.

Authors:  Qiong Ye; Guo-Ping Tian; Hai-Peng Cheng; Xin Zhang; Xiang Ou; Xiao-Hua Yu; Ru-Qi Tan; Feng-Yun Yang; Duo Gong; Chong Huang; Yan-Jun Pan; Jie Zhang; Ling-Yan Chen; Zhen-Wang Zhao; Wei Xie; Liang Li; Min Zhang; Xiao-Dan Xia; Xi-Long Zheng; Chao-Ke Tang
Journal:  J Atheroscler Thromb       Date:  2017-09-01       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.